Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
Public ClinicalTrials.gov record NCT00071253. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind Study of Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
Study identification
- NCT ID
- NCT00071253
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Abbott
- Industry
- Enrollment
- 180 participants
Conditions and interventions
Conditions
Interventions
- Divalproex Sodium (Delayed-Release Tablets) Drug
- Divalproex Sodium (Extended-Release Tablets) Drug
- Olanzapine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2003
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Aug 3, 2006
Started 2003
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Behavioral and Medical Research, LLC | Anaheim | California | 92805 | — |
| Synergy Clinical Research | Chula Vista | California | 91910 | — |
| Clinical Trial Management | Fort Meyers | Florida | 33907 | — |
| Segal Institute for Clinical Research | North Miami | Florida | 33161 | — |
| Rush Presbyterian - St. Luke's | Chicago | Illinois | 60612 | — |
| University of Louisville Outpatient Psychiatry | Louisville | Kentucky | 40202 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Creighton University Department of Psychiatry | Omaha | Nebraska | 68131 | — |
| Lake Mead Hospital | North Las Vegas | Nevada | 89030 | — |
| NYU School of Medicine | New York | New York | 10016 | — |
| University Hospital of Cleveland | Cleveland | Ohio | 44106 | — |
| R. Ranjan, MD & Associates, Inc. | Lyndhurst | Ohio | 44124 | — |
| IPS Research | Oklahoma City | Oklahoma | 73103 | — |
| UTMB Dept. of Psychiatry | Galveston | Texas | 77555-0197 | — |
| Zablocki VAMC | Milwaukee | Wisconsin | 53295 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00071253, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2006 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00071253 live on ClinicalTrials.gov.